Clinical Trials for Patients in Africa

Get Permission

Thank you very much for The ASCO Post Evening News,* which ensures I don’t miss anything that happened at the ASCO 2013 meeting.

Due to financial constraints I could not attend the ASCO Annual Meeting in Chicago.

My comment is that pharmaceutical companies should extend their oncology drug trials to Africa so our patients can benefit from the new drugs and also to assess their pharmacogenomics. It is not fair to conduct all trials in Europe and North America and sell expensive drugs in Africa. ■

—Ogidiagba Louis Efe, MBBS

Dr. Ogidiagba Louis Efe is a member of ASCO and Senior Registrar in General Surgery, Department of Surgery, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria. 

*The ASCO Post Evening News is delivered via email Monday through Friday evenings. It is circulated to all members of ASCO worldwide. 

Visit to learn more.




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.